Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
Clinical trial NCT07403552 · RECRUITING
Trial details
- NCT number
- NCT07403552
- Sponsor
- Ensho Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2026-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.